Eric Moessinger

Eric joined NanoDimension in 2008 and was the first employee of NanoDimension’s Silicon Valley office. He is focused on life sciences investments. Eric is currently board member of Emulate, SQZ Biotech, Serotiny, Amphivena and a board observer of Inscripta and Click Diagnostics. He previously observed on the board of ARMO (acquired by Lilly), Twist Bioscience (Nasdaq: TWST) and IonPath. Eric helped lead NanoDimension’s investments in Orca and Octant. Before joining NanoDimension, Eric was a consultant at Bain & Company in Zurich and San Francisco. While at Bain, Eric worked on strategy cases in healthcare, industrial goods and telecommunications and on the turn-around of an electrical component manufacturer. In addition, Eric spent eight months in Bain’s Private Equity Group. Eric has an MS.c. from the London School of Economics and a BS/BA from the University of Florida.

Board of Directors

Peter Van Vlasselaer

Peter Van Vlasselaer, Ph.D.

Executive Chairman

Eric Moessinger

Eric Moessinger

NanoDimension

Mark McDade

Mark McDade

Qiming Venture Partners USA

Luke Evnin

Luke Evnin, Ph.D.

MPM Capital

Christian Richard

Christian Richard

Tekla Capital Management LLC

Jeanmarie Guenot

Jeanmarie Guenot, Ph.D.

Founder, President & CEO